Maria Lane

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma”.

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

Frontiers in Oncology(2020)10.3389/fonc.2020.00302

N/A

0DataRank · unranked

16 citations

Hakon Hakonarson, Kevin Y. Huang, Pichai Raman, Komal S. Rathi, Daniel Martínez +7 more

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100344

N/A

0DataRank · unranked

34 citations

Samantha N. Buongervino, Maria Lane, Doncho V. Zhelev, Zhongyu Zhu, Hong Cui +15 more

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.06.451385

N/A

0DataRank · unranked

5 citations

Crystal Griffin, Hakon Hakonarson, Allison Stern, Cameron Brimley, Komal S. Rathi +13 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390

N/A

0DataRank · unranked

5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003

N/A

0DataRank · unranked

18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more